1-2 of 2
Aniek O. De Graaf, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mutation Profiles Identify Distinct Clusters of Lower Risk Myelodysplastic Syndromes with Unique Clinical and Biological Features and Clinical Endpoints

Luca Malcovati, MD, Simon Crouch, PhD BA, MA, MSc, Aniek O. De Graaf, PhD, Sarah Sandmann, Magnus Tobiasson, MD, Olivier Kosmider, PharmD, PhD, Bert A. van der Reijden, PhD, Daniel Painter, BSc, Arjan A. Van de Loosdrecht, MD PhD, Argiris Symeonidis, MD PhD, Jaroslav Cermak, MD PhD, Emmanuelle Clappier, PharmD,PhD, Claude Preudhomme, MD PhD, Reinhard Stauder, MD MSc, Moshe Mittelman, MD, Ulrich Germing, David Bowen, MD, Pierre Fenaux, MD PhD, Corine Van Marrewijk, PhD, Alexandra Smith, PhD, Martin Dugas, Eva Hellstrom Lindberg, MD PhD, Theo M de Witte, MD, Michaela Fontenay, Joop Jansen, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 29.
https://doi.org/10.1182/blood-2020-138549
Published: 2020
Journal Articles

Machine Learning-Based Flow Cytometry Diagnostics in Myelodysplastic Syndromes: Validation in the HOVON89 Clinical Trial (EudraCT 2008-002195-10)

Carolien Duetz, MD, Sofie Van Gassen, PhD, Theresia M. Westers, PhD, Florentien in t Hout, MDPhD, Eline Cremers, MDPhD, Canan Alhan, MD PhD, Costa Bachas, PhD, Margot F. Van Spronsen, MD, Heleen Visser-Wisselaar, Dana Chitu, Aniek O. De Graaf, PhD, Joop Jansen, PhD, Yvan Saeys, PhD, Arjan van de Loosdrecht, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–12.
https://doi.org/10.1182/blood-2020-136719
Published: 2020